CA-May13-Doc.1

DRAFT AGENDA

51st meeting of representatives of Members States Competent Authorities for the implementation of Directive 98/8/EC concerning the placing of biocidal products on the market

15-17 May 2013

Starting at 09:30 on 15 May – Ending at 16:00 on 17 May2013

1

15 May
Registration 09:00 – 09:30
Morning Session / 09:30 – 13:00
  1. Adoption of the agenda
/ For adoption
CA-May13-Doc.1
  1. Adoption of the draft minutes of the previousCA meeting
/ For adoption
CA-May13-Doc.2 – with comments from FR, SK and UK
  1. Final discussions on draft regulatory measures

3.0Note on the principles for taking decisions on the approval of active substances / For discussion
CA-May13-Doc.3.0
3.1.Draft Commission implementing Regulation and draft assessment report for the approvalof cypermethrin for PT 8 / For discussion
RMS: BE
CA-May13-Doc.3.1
CA-May13-Doc.3.1a
3.2.Draft Commission implementing Regulation and draft assessment report for the approvalof propiconazole for PT 9 / For discussion
RMS: FI
CA-May13-Doc.3.2
CA-May13-Doc.3.2a
  1. First discussions on draft regulatory measures

4.1.Draft Commission implementing Regulation and draft assessment report for the approvalof IPBC for PT 6 / For discussion
RMS: DK
CA-May13-Doc.4.1
CA-May13-Doc.4.1a
4.2.Draft Commission implementing Regulation and draft assessment report for the approvalof Tebuconazole for PT 7 and 10 / For discussion
RMS: DK
CA-May13-Doc.4.2
CA-May13-Doc.4.2a
CA-May13-Doc.4.2b
4.3.Draft Commission implementing Regulation and draft assessment report for the approvalof Benzoic acid for PT 3 and 4 / For discussion
RMS: DE
CA-May13-Doc.4.3
CA-May13-Doc.4.3a
CA-May13-Doc.4.3b
4.4.Draft Commission implementing Regulation and draft assessment report for the approvalof Aluminium phosphide for PT 20 / For discussion
RMS: DE
CA-May13-Doc.4.4
CA-May13-Doc.4.4a
15 May
Afternoon SESSION / 14:30 – 18:00
4.5.Draft Commission implementing Regulation and draft assessment report for the approvalof Etofenprox for PT 18 / For discussion
RMS: AT
CA-May13-Doc.4.5
CA-May13-Doc.4.5a
4.6.Draft Commission implementing Regulation and draft assessment report for amending the conditions ofapprovalof Nonanoic acid for PT 2 / For discussion
RMS: AT
CA-May13-Doc.4.6
CA-May13-Doc.4.6a
4.7.Draft Commission implementing Regulation and draft assessment report for the approvalof Bromoacetic acid for PT 4 / For discussion
RMS: ES
CA-May13-Doc.4.7
CA-May13-Doc.4.7a
4.8.Draft Commission implementing Regulationand draft assessment report for the approval of Copper sulphate for PT 2 / For discussion
RMS: FR
CA-May13-Doc.4.8
CA-May13-Doc.4.8a
4.9.Proposal for a Commission implementing Regulation specifying the procedures to amendAnnex I / For discussion
CA-May13-Doc.4.9
4.10.Proposal for a Commission Regulation (delegated act) concerning the review programme / For information
16 May
Morning SESSION / 9:30 – 12:30
  1. New Regulation

5.1.Preparation of implementation
5.1.a.Tasks overview / For information
CA-May13-Doc.5.1.a
CA-May13-Doc.5.1.aa
5.1.b.Follow-up from previous discussions
  • Report from the CA / ECHA MB meeting held on 18/19 April 2013
  • Technical equivalence
  • Confidentiality claims check (with some clarification on dissemination)
  • IT security requirements
  • IT roll-out plan
  • Draft Article 95 list
/ For information
5.1.c.Draft ECHA Guidance document on information requirements / For discussion
CA-May13-Doc.5.1.c
5.1.d.Treated articles / For discussion
CA-May13-Doc.5.1.d
5.1.e.Borderline cosmetics/biocides / For discussion
CA-May13-Doc.5.1.e
5.1.f.Biocides and food contact materials / For information
5.1.g.Biocides and nanomaterials / For endorsement
CA-May13-Doc.5.1.g
5.1.h.Comparative assessment / For discussion
CA-May13-Doc.5.1.h
16 May
Afternoon Session / 14:30 – 18:00
5.1.i.MRLs / For information
5.1.j.Mutual recognition agreement with Switzerland / For information
5.1.k. Biocidesand Medical Devices / For endorsement
CA-May13-Doc.5.1.k
5.2.Problems identified in new Regulation
5.2.a.Draft Commission proposal to amend Regulation (EU) No 528/2012 / For information
5.3.Questions regarding the new Regulation / For endorsement
CA-May13-Doc.5.3
5.3.a Additional questions regarding the new Regulation / For discussion
CA-May13-Doc.5.3.a
CA-May13-Doc.5.3.b
5.4.Classification and labelling / For endorsement
CA-May13-Doc.5.4
17 May
Morning Session / 9:30 – 12:30
  1. Policy matters

6.1.Technical meetings
6.2.Guidance documents
6.2.a. Guidance documents on environmental risk mitigation measures for PT 1-5 / For information
6.2.b. Guidance document on the evaluation of efficacy of disinfectants PT2 / For endorsement
CA-May13-Doc.6.2.b
6.2.c.Food and feed derogation / For endorsement
CA-May13-Doc.6.2.c
6.2.d.Evaluation manual for product authorisation / For endorsement
CA-May13-Doc.6.2.d
  1. Requests for opinions

7.1.Chlorine generated by combination of urea and sodium hypochlorite / For endorsement
CA-May13-Doc.7.1
7.2.Preservatives in dipping baths / For discussion
CA-May13-Doc.7.2
7.3.Appropriate PT for biocides used in oil extraction / For discussion
CA-May13-Doc.7.3
  1. Review programme

8.1.Progress report on substances under evaluation / For information
CA-May13-Doc.8.1
8.2.Annex I-inclusions - Deadlines for decision making / For information
CA-May13-Doc.8.2
8.3.Establishment of a work programme to meet the 2024 deadline[1] / For discussion
CA-May13-Doc.8.3
8.4.Questions on in situ generated CO2 / For discussion
CA-May13-Doc.8.4
8.5.Policy issues related to the evaluation of silver / For information
CA-May13-Doc.8.5a-c
  1. New active substances

9.1.Progress report on substances under evaluation / For information
CA-May13-Doc.9.1
  1. Enforcement and implementation issues

10.1.Use of copper in PT2, 5 and 11 / For information
CA-May13-Doc.10.1
10.2.Report on Risk mitigation measures for rodenticides / For information
CA-May13-Doc.10.2
CA-May13-Doc.10.2.a
  1. Product authorisations

11.1.Report from the Product Authorisation and Mutual Recognition Facilitation Group / For information
11.2.Status report on notifications made in accordance with Article 4(4) of the Directive / For information
CA-May13-Doc.11.2
11.3.Application of Article 23(4) of the BPR to anticoagulant rodenticides for which the authorisation decision will be taken after 1 September 2013 / For discussion
CA-May13-Doc.11.3
17 May
Afternoon Session / 14:00 – 16:00
  1. New policy developments which may affect the biocides regulatory framework

12.1.Commission recommendation establishing guidelines for the distinction between feed materials, feed additives, biocidal products and veterinary medicinal products / For information
12.2.6th ad hoc group meeting under the Community Strategy for endocrine disruptors / For information
12.3.Commission proposal for a Directive of the European Parliament and of the Council amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy / For information
CA-May13-Doc.12.3
12.4.EFSA conclusions on neonicotinoids and bees. / For information
  1. International Matters

13.1.FAO code of conduct / For information
CA-May13-Doc.13.1
  1. AOB

14.1.List of Competent Authorities and other Contact Pointsand of list of Members of the Consultation Group / For information
CA-May13-Doc. 14.1
CA-May13-Doc. 14.1a

Next meetings (provisional):

2013

PA&MRFG / CA / TM / BPC
14 May 2013 / 15 -17 May 2013 / TM II 10-14 June 2013 / 29-30 May 2013
9 July 2013 / 10 - 12 July 2013
24 - 25 September 2013 / 25 - 27 September 2013 / TM III 16-20 September 2013 / 9-10 October 2013
8 October 2013 (pm)
(tbd) December 2013 / 10 - 12 December 2013 / TM IV 25-29 November 2013

2014-2015

CG / CA / BPC
15 January 2014 / 11-13 February 2014
11 March 2014 / 12-14 March 2014 / 8-10 April 2014
13 May 2014 / 14-16 May 2014 / 17-19 June 2014
10 July 2014 / 30 September - 2 October 2014
16 September 2014 / 17-19 September 2014 / 2-4 December 2014
11 November 2014 / 12-14 November 2014 / 3-5 February 2015
14-16 April 2015
16-18 June 2015
29 September - 1 October 2015
1-3 December 2015

1

[1]This item will be discussed on 16 May (afternoon)